KEYNOTE-155:A Phase Ib trial of pembrolizumab (MK-3475) in combination with dinaciclib (MK-7965) in subjects with hematologic malignancies

March 02, 2016
https://clinicaltrials.gov/ct2/show/NCT02684617
Cancer - Leukemia
Principal Investigator: Ding Wang, MD
Hematologic malignancies
Accepting Participants
(313)916-1784